Intangible Assets

IDAI does not appear to have a durable proprietary asset base or protected IP that meaningfully sustains pricing power versus peers, so any product differentiation is likely replicable.

The absence of disclosed long-run profitability or margin history in the provided metrics suggests no evidence of brand-led or patent-led economics that would support peer-leading retention.

Compared with established healthcare or AI software peers that can point to regulated data, clinical workflows, or entrenched IP, IDAI’s moat from intangible assets looks materially weaker and less durable.

Switching Costs

The negative TTM ROIC and ROCE indicate customers are not yet locked in by high switching costs that translate into durable excess returns.

A cash conversion cycle of 34.7 days does not by itself indicate customer captivity, and the provided data do not show contract structures or workflow dependence that would raise switching friction.

Relative to peers with embedded software, regulated integrations, or mission-critical workflows, IDAI appears to have limited evidence of retention-based moat strength.

Network Effects

The provided information does not show a user, data, or ecosystem flywheel that would make the product more valuable as adoption rises.

Negative invested-capital returns imply the company is not yet monetizing any network-driven scale benefits into durable economics.

Compared with platform peers where more users, data, or developers reinforce product value, IDAI shows no visible network effect advantage.

Cost Advantage

The negative ROIC and ROCE suggest IDAI is not operating with a cost structure that converts into superior unit economics versus peers.

Asset turnover of 0.28x indicates weak capital productivity, which is inconsistent with a durable cost advantage.

Relative to more efficient peers, IDAI does not currently demonstrate a lower-cost delivery model that would protect margins over 5–10 years.

Efficient Scale

The available metrics do not indicate that IDAI operates in a market structure where scale alone creates a strong barrier to entry or sustained pricing power.

Negative returns on capital suggest any scale benefits are not yet sufficient to deter competitors or support durable excess returns.

Compared with larger incumbents in adjacent software or healthcare technology markets, IDAI does not appear to have reached efficient-scale conditions that materially constrain peer competition.

Overall Score

IDAI shows no clear evidence of a durable moat across the five structural drivers, and the provided metrics point to weak capital efficiency and negative returns rather than peer-leading pricing power or retention. Relative to stronger peers, the company appears replicable and lacks the switching costs, network effects, or scale advantages needed for a durable competitive advantage.